Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

/sup 195m/Au, an ultra-short-lived generator-produced radionuclide: clinical application in sequential first pass ventriculography

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:5997634
/sup 195m/Au (Au-195m) has a half-life of 30.5 sec and can be produced at the bedside from the parent /sup 195m/Hg (T 1/2 . 41.6 hr). The generator produced sterile pyrogen-free /sup 195m/Au with mercury breakthrough of 0.75 +/- 0.09 (s.e.m.) muCi per mCi of /sup 195m/Au. Approximately 20 to 25 mCi of /sup 195m/Au was produced per elution from a generator containing 155 mCi of /sup 195m/Hg. We compared first-pass resting /sup 99m/Tc angiograms with /sup 195m/Au angiograms in 28 patients. The correlation coefficient between the two studies was 0.92 over an ejection-fraction range from 0.22 to 0.83. In addition, we tested the reproducibility of /sup 195m/Au first-pass angiograms by performing two studies 3 min apart. In 25 patients with ejection fractions ranging from 0.20 to 0.78, the correlation coefficient between such pairs was 0.93. The nuclide is reliably and reproducibly produced, and its short half-life allows the performance of background-free sequential first-transit studies with unusually low radiation exposure to the patient.
Research Organization:
Harbor-UCLA Medical Center, Torrance, California
OSTI ID:
5997634
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 24:2; ISSN JNMEA
Country of Publication:
United States
Language:
English